The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
about
The CB2 receptor and its role as a regulator of inflammationEndocannabinoid signalling in innate and adaptive immunity.Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.Update on the role of cannabinoid receptors after ischemic stroke.Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Role of matrix metalloproteinase-8 in atherosclerosisTreatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in miceModulating the endocannabinoid system in human health and disease--successes and failuresIntraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis.Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke.Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology.Carotid atherosclerotic plaque stenosis: the stabilizing role of statins.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Role of neutrophils in atherogenesis: an update.Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.Neutrophils as protagonists and targets in chronic inflammation.Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study.Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritisDiminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention.Mechanism of platelet activation induced by endocannabinoids in blood and plasma.Alamandine abrogates neutrophil degranulation in atherosclerotic mice.The role of monocytosis and neutrophilia in atherosclerosis.The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.
P2860
Q28066700-0E7F9DD2-9DFD-4F13-83D2-09085C21BA44Q34458059-80E57B60-8222-46B1-B0CC-8441341B576CQ35125558-C332493E-C5F1-4A4F-806E-522182D3D2A9Q35501238-F9DC46D9-466F-4A6C-B42C-A7E743926344Q35854652-28AB65C8-8B4C-42DC-A605-96CE122C12C6Q35915645-DD895877-90E1-4667-B838-7AC380A7C9CAQ36089227-3D3C7082-4974-4365-BA45-7CFE07A23BD2Q36346915-366CACF5-5FB8-40C7-90AD-C8901B35596FQ36567357-D7A64D93-7C21-497A-BF25-CAA26A6DDF56Q36745089-08AB211B-73DD-4954-8153-30876886882DQ36933683-7D4EA44E-8F24-4633-8B8E-749D957069CCQ37310466-C63DACD6-472F-482F-AC05-DEC12BEE3A13Q37330515-FB6EAF89-0676-448C-942D-F1D1B2201F95Q38040358-0C58286D-BF0F-4ACA-BBE7-EC39E5BE24CEQ38068594-69FA5CBE-6875-4F8A-A373-41A451BA784DQ38251322-57EF0236-16C6-445E-9CFE-974667568DF1Q38468985-AC3683A0-347C-4D42-8C2E-FF5447D09B7DQ38634721-BA9506F6-049E-4164-B2CA-28ED9F5608B6Q38851279-3A3FCF20-F6A0-4C14-BEE9-C4D22A7C7D42Q39175804-505285F0-985D-4AFC-AB52-F45E5719DC39Q41217657-DBFE68BC-94F8-4629-A17A-304710B2435FQ41531870-81189F0D-2EEB-4BA4-A57D-0F9B9583AB67Q41572699-C25CA43C-584D-484F-ADAF-09650EF02BA2Q42904836-EE8A677B-DC44-43F2-878A-B11A68D2F11EQ44500279-564FBEA6-B897-4207-A55C-0671C92548C5Q47847982-C2E1CE0D-2030-4574-87CB-D4812DB01433Q48175299-F5467E40-3B2C-4FF7-8B2E-FE791E0C24A5Q50142905-3A8FE025-9B5C-42C7-ABDD-EAADB659087F
P2860
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The activation of the cannabin ...... ty in atherosclerotic plaques.
@ast
The activation of the cannabin ...... ty in atherosclerotic plaques.
@en
type
label
The activation of the cannabin ...... ty in atherosclerotic plaques.
@ast
The activation of the cannabin ...... ty in atherosclerotic plaques.
@en
prefLabel
The activation of the cannabin ...... ty in atherosclerotic plaques.
@ast
The activation of the cannabin ...... ty in atherosclerotic plaques.
@en
P2093
P2860
P50
P921
P356
P1476
The activation of the cannabin ...... ity in atherosclerotic plaques
@en
P2093
Aldo Pende
Bianca Pane
Domenico Palombo
Fabienne Burger
François Mach
Giovanni Spinella
Graziano Pelli
Katia Galan
Kristina Kuzmanovic
Luciano Capettini
P2860
P304
P356
10.1093/EURHEARTJ/EHR449
P50
P577
2011-11-22T00:00:00Z